Corporate Finance

Teal Health's FDA-authorized Teal Wand is now available in all 50 states, aiming to revolutionize preventive care for millions of overdue women.

Omaha-based Core Bank partners with Kobalt Labs, using AI to slash risk review times from days to minutes and safely accelerate its embedded banking strategy.

A Boston biotech, armed with $62M and a new name, unveils a plan to build a universal model of the cell, aiming to predict and control its behavior.

A $7M auction saw a Purdey gun fetch $209K, revealing a red-hot market where history, craftsmanship, and investment potential drive record prices.

Blockchain firm BTCS reports 290% revenue growth, pioneering a new model that blends DeFi with public markets to build an Ethereum powerhouse.

Wearable Devices and Rokid partner to bring touchless gesture control to smart glasses, promising a future where a flick of a finger runs your world.

As Harmony Biosciences presents at JPM, investors will scrutinize its strategy for sustaining growth beyond its star drug and advancing its rare disease pipeline.

Instead of selling out, the family-owned natural products giant is making its 1,800 employees owners, securing a legacy of independence and community focus.

With $16.4M in new funding, STRM.BIO is advancing a novel gene therapy platform that uses natural vesicles to target bone marrow, offering new hope for rare diseases.

Palisade Bio's PALI-2108, a drug targeting IBD at its source, secures a key investment, offering hope for a new era of treatment with fewer side effects.

A new global study shows consumers embrace AI for product research but don't trust it for purchases, revealing a 'Confidence Economy' ruled by transparency.

A new partnership brings a complex wealth-building insurance product to the digital age, offering instant decisions and no medical exams. Is this the future?

Fresh off its 'Fierce 15' win, Recludix Pharma and its billion-dollar Sanofi pact take the spotlight with a novel oral drug for inflammatory diseases.

Universal Insurance Holdings announces a new $20M stock buyback, signaling strong financial health and confidence amidst a stabilizing Florida market.

A new joint venture provides crucial short-term loans, aiming to unlock permanent financing for affordable housing projects facing a critical funding gap.

With a massive $200M Series C, Soley Therapeutics is using its AI cell-sensing platform to fast-track novel cancer drugs from code to clinic.

A new Deloitte study shows EV interest stalling as affordability woes and practical concerns push buyers back to gas and hybrids, rocking brand loyalty.

A major new partnership aims to consolidate the industrial services sector, fueled by private equity and a national infrastructure spending boom.

As Sotera Health prepares for the J.P. Morgan conference, strong financials clash with legal challenges, putting its mission-critical role under scrutiny.

A Tennessee company's patented 1-to-1 CBD and CBDA formula shows promise in fighting inflammation, setting the stage for a new class of FDA-regulated drugs.